跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STREPSILS EXTRA hexylresorcinol 2.4 mg blackcurrant flavour lozenge blister pack (reformulation) - TGA Drug Approval Details
Approvals
/
TGA
/
STREPSILS EXTRA hexylresorcinol 2.4 mg blackcurrant flavour lozenge blister pack (reformulation)
Approved
STANDARD
STREPSILS EXTRA hexylresorcinol 2.4 mg blackcurrant flavour lozenge blister pack (reformulation)
Reckitt Benckiser Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
9b4630f001e42463
Company
Reckitt Benckiser Pty Ltd
Type
Standard
Approval Details
Approval Id
9b4630f001e42463
Product Name
STREPSILS EXTRA hexylresorcinol 2.4 mg blackcurrant flavour lozenge blister pack (reformulation)
Artg Id
82802
Artg Name
STREPSILS EXTRA hexylresorcinol 2.4 mg blackcurrant flavour lozenge blister pack (reformulation)
Sponsor
Reckitt Benckiser Pty Ltd
Company Detail Path
/organization/reckitt-benckiser-australia-pty-ltd
Artg Date
2002-05-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
9b4630f001e42463
Type
Standard
Back to TGA Approvals